Maedi-visna control in sheep. III: Results and evaluation of a voluntary control program in The Netherlands over a period of four years.
The results of the first four years of the Dutch national voluntary maedi-visna control program, which was launched on January 1, 1982, are presented. At the end of the observation period, 1711 breeding flocks representing 70% of the registered breeding flocks participated. The program is based on accreditation of flocks that have passed two successive serological tests with an interval of six months between and post-accreditation tests every 12 months. The flocks have to conform to a set of specific regulations. Sheep sold from such flocks receive a certificate stating that their origin was accredited. A total of 1212 flocks gained accreditation. Of these flocks, 29.5% were free from infection from the beginning, 35.6% were created by total replacement of the original stock, 19.6% employed repeated testing and culling of positives, and 15.3% were created by artificial rearing of colostrum-deprived lambs. A total of 22 flocks lost accreditation due to detection of 36 seropositives. These positives and their progeny were culled, and all flocks regained accreditation after passing the two negative flock tests required. In a total of seven flocks, an unusual course of events during the pre-accreditation stage was observed; this was mainly attributed to late seroconversions and uncommon degrees of horizontal transmission. The results indicate that this certification yields a substantial guarantee of freedom from maedi-visna virus and they indirectly show that the basic design of the program has been adequate.
Houwers
D J
DJ
Central Veterinary Institute, Lelystad.
König
C D
CD
Bakker
J
J
de Boer
M J
MJ
Pekelder
J J
JJ
Sol
J
J
Vellema
P
P
de Vries
G
G
D000818:Animals; D000914:Antibodies, Viral / Q000032:analysis; D009426:Netherlands; D011021:Pneumonia, Progressive Interstitial, of Sheep / Q000517:prevention & control*; D012756:Sheep; D014790:Visna-maedi virus / Q000276:immunology
D000914:Antibodies, Viral